MetLife Investment Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-33,813
| Closed | -$2.3M | – | 2879 |
|
|
2022
Q3 | $2.3M | Buy |
33,813
+641
| +2% | +$43.7K | 0.02% | 820 |
|
|
2022
Q2 | $1.06M | Sell |
33,172
-1,231
| -4% | -$39.3K | 0.01% | 1175 |
|
|
2022
Q1 | $1.19M | Buy |
34,403
+12,697
| +58% | +$440K | 0.01% | 1219 |
|
|
2021
Q4 | $635K | Hold |
21,706
| – | – | 0.01% | 1382 |
|
|
2021
Q3 | $553K | Hold |
21,706
| – | – | 0.01% | 1465 |
|
|
2021
Q2 | $760K | Buy |
+21,706
| New | +$760K | 0.01% | 1328 |
|
|
2020
Q2 | – | Sell |
-24,047
| Closed | -$1.23M | – | 2379 |
|
|
2020
Q1 | $1.23M | Sell |
24,047
-1,343
| -5% | -$68.6K | 0.02% | 814 |
|
|
2019
Q4 | $2.02M | Hold |
25,390
| – | – | 0.02% | 813 |
|
|
2019
Q3 | $1.23M | Buy |
25,390
+958
| +4% | +$46.5K | 0.01% | 971 |
|
|
2019
Q2 | $1.29M | Buy |
24,432
+1,335
| +6% | +$70.2K | 0.01% | 1003 |
|
|
2019
Q1 | $1.22M | Hold |
23,097
| – | – | 0.01% | 998 |
|
|
2018
Q4 | $948K | Hold |
23,097
| – | – | 0.01% | 1038 |
|
|
2018
Q3 | $878K | Hold |
23,097
| – | – | 0.01% | 1200 |
|
|
2018
Q2 | $1.04M | Buy |
23,097
+5,516
| +31% | +$249K | 0.01% | 1002 |
|
|
2018
Q1 | $849K | Hold |
17,581
| – | – | 0.01% | 1076 |
|
|
2017
Q4 | $692K | Buy |
+17,581
| New | +$692K | 0.01% | 1211 |
|